Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,637 results that match your search.22,637 results
  • Online sellers may have to change their attitude to counterfeits after a Court of Justice ruling in Europe. But eBay had some consolation, says James Nurton
  • The USPTO is prepared to begin implementing patent reform as soon as the America Invents Act clears Congress and is signed into law, a top official said yesterday
  • One hundred years after the first piece of litigation over Budweiser beer, four recent decisions show the battle is far from over – despite a major decision from the Court of Justice of the EU (CJ). In the first, Argentina made a final ruling that Czech brewery Budweiser Budvar cannot register its trade mark after an opposition from US brewer Anheuser-Busch. In the second and third, Budvar won cases in Bulgaria and Italy. Which was perhaps surprising, given the bigger decision earlier in the year from the CJ ruling that Budvar's geographical indication for Bud did not give it protection against competing trade marks.
  • The US Federal Circuit has weighed in on yet another patent eligibility case following the Supreme Court’s In re Bilski ruling, finding two of the three claims in Classen v Biogen to be patentable subject matter
  • A decision by a UDRP panellist that again rejects the so-called Octogen line on bad faith has raised doubts about the sustainability of the doctrine
  • Last month there were several overlapping developments in UK copyright. Internet service provider BT was forced to block infringing website Newzbin in a court judgment – the first time this has happened in the UK – but at the same time regulator Ofcom said it would not be implementing a part of the Digital Economy Act that would have made such blocking uniform.
  • The biotech industry can breathe a sigh of relief, for now. The Federal Circuit's ruling in Association for Molecular Pathology v the USPTO and Myriad Genetics found that isolated DNA sequences can be patented. Until, that is, the US Supreme Court takes on the case, which seems likely if the case is appealed.
  • The European Commission will reveal the findings of its review of trade mark law in the new year. James Nurton of Managing IP and Tove Graulund, who has been following developments for MARQUES, give you a 10-point cheat sheet
  • A fifth advertising organisation has expressed its concerns over the new gTLD programme.
  • The EU and India have reached a temporary agreement in their dispute over the seizure at EU ports of Indian generic drugs in transit